United States Biosimilar Monoclonal Antibodies Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Biosimilar Monoclonal Antibodies

Revenue, means the sales value of Biosimilar Monoclonal Antibodies

This report studies sales (consumption) of Biosimilar Monoclonal Antibodies in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Celltrion

- Boehringer Ingelheim

- Dr Reddy's

- Sandoz

- Zydus

- Samsung

- Amgen

- Hospira

- Shanghai CP Guojian Pharmaceutical

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Monoclonal Antibodies in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Biosimilar Monoclonal Antibodies Market Report 2016

Table of Contents
United States Biosimilar Monoclonal Antibodies Market Report 2016
1 Biosimilar Monoclonal Antibodies Overview
1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
1.2 Classification of Biosimilar Monoclonal Antibodies
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Biosimilar Monoclonal Antibodies
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Biosimilar Monoclonal Antibodies (2011-2021)
1.4.1 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2021)
1.4.2 United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
2 United States Biosimilar Monoclonal Antibodies Competition by Manufacturers
2.1 United States Biosimilar Monoclonal Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biosimilar Monoclonal Antibodies Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biosimilar Monoclonal Antibodies Average Price by Manufactures (2015 and 2016)
2.4 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends
2.4.1 Biosimilar Monoclonal Antibodies Market Concentration Rate
2.4.2 Biosimilar Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Biosimilar Monoclonal Antibodies Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2011-2016)
3.2 United States Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)
3.3 United States Biosimilar Monoclonal Antibodies Price by Type (2011-2016)
3.4 United States Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2011-2016)
4 United States Biosimilar Monoclonal Antibodies Sales (Volume) by Application (2011-2016)
4.1 United States Biosimilar Monoclonal Antibodies Sales and Market Share by Application (2011-2016)
4.2 United States Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Biosimilar Monoclonal Antibodies Manufacturers Profiles/Analysis
5.1 Celltrion
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Boehringer Ingelheim
5.2.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Dr Reddy's
5.3.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sandoz
5.4.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Zydus
5.5.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Samsung
5.6.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Amgen
5.7.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Hospira
5.8.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Shanghai CP Guojian Pharmaceutical
5.9.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
6 Biosimilar Monoclonal Antibodies Manufacturing Cost Analysis
6.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Biosimilar Monoclonal Antibodies Market Forecast (2016-2021)
10.1 United States Biosimilar Monoclonal Antibodies Sales, Revenue Forecast (2016-2021)
10.2 United States Biosimilar Monoclonal Antibodies Sales Forecast by Type (2016-2021)
10.3 United States Biosimilar Monoclonal Antibodies Sales Forecast by Application (2016-2021)
10.4 Biosimilar Monoclonal Antibodies Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Biosimilar Monoclonal Antibodies
Table Classification of Biosimilar Monoclonal Antibodies
Figure United States Sales Market Share of Biosimilar Monoclonal Antibodies by Type in 2015
Table Application of Biosimilar Monoclonal Antibodies
Figure United States Sales Market Share of Biosimilar Monoclonal Antibodies by Application in 2015
Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2021)
Figure United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Table United States Biosimilar Monoclonal Antibodies Sales of Key Manufacturers (2015 and 2016)
Table United States Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Figure 2016 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Table United States Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2015 and 2016)
Table United States Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table 2016 United States Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table United States Market Biosimilar Monoclonal Antibodies Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biosimilar Monoclonal Antibodies Average Price of Key Manufacturers in 2015
Figure Biosimilar Monoclonal Antibodies Market Share of Top 3 Manufacturers
Figure Biosimilar Monoclonal Antibodies Market Share of Top 5 Manufacturers
Table United States Biosimilar Monoclonal Antibodies Sales by Type (2011-2016)
Table United States Biosimilar Monoclonal Antibodies Sales Share by Type (2011-2016)
Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2015
Table United States Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)
Table United States Biosimilar Monoclonal Antibodies Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type (2011-2016)
Table United States Biosimilar Monoclonal Antibodies Price by Type (2011-2016)
Figure United States Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2011-2016)
Table United States Biosimilar Monoclonal Antibodies Sales by Application (2011-2016)
Table United States Biosimilar Monoclonal Antibodies Sales Market Share by Application (2011-2016)
Figure United States Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2015
Table United States Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2011-2016)
Figure United States Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Dr Reddy's Basic Information List
Table Dr Reddy's Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr Reddy's Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Zydus Basic Information List
Table Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Samsung Basic Information List
Table Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Basic Information List
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Major Buyers of Biosimilar Monoclonal Antibodies
Table Distributors/Traders List
Figure United States Biosimilar Monoclonal Antibodies Production and Growth Rate Forecast (2016-2021)
Figure United States Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Table United States Biosimilar Monoclonal Antibodies Production Forecast by Type (2016-2021)
Table United States Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2016-2021)
  • United States, EU, Japan, China, India and Southeast Asia Pharmacy Automation Market Size, Status and Forecast 2021
    Published: 05-Dec-2016        Price: US 3300 Onwards        Pages: 106
    Notes: Production, means the output of Pharmacy Automation Revenue, means the sales value of Pharmacy Automation This report studies the global Pharmacy Automation market, analyzes and researches the Pharmacy Automation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - BD - Baxter International - TOSHO - Takazono - Omnicell......
  • United States, EU, Japan, China, India and Southeast Asia Outsourced Orthopedic Manufacturing Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 111
    Notes: Production, means the output of Outsourced Orthopedic Manufacturing Revenue, means the sales value of Outsourced Orthopedic Manufacturing This report studies the global Outsourced Orthopedic Manufacturing market, analyzes and researches the Outsourced Orthopedic Manufacturing development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Tecomet - Orchi......
  • United States, EU, Japan, China, India and Southeast Asia Continuous Positive Airway Pressure Therapy Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 112
    Notes: Production, means the output of Continuous Positive Airway Pressure Therapy Revenue, means the sales value of Continuous Positive Airway Pressure Therapy This report studies the global Continuous Positive Airway Pressure Therapy market, analyzes and researches the Continuous Positive Airway Pressure Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like......
  • United States, EU, Japan, China, India and Southeast Asia Biosimulation Market Size, Status and Forecast 2021
    Published: 02-Dec-2016        Price: US 3300 Onwards        Pages: 94
    Notes: Production, means the output of Biosimulation Revenue, means the sales value of Biosimulation This report studies the global Biosimulation market, analyzes and researches the Biosimulation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Certara - Simulation Plus - Dassault Systèmes - Schr?dinger - Advanced Chemistry D......
  • United States Hair Loss and growth Treatments and Products Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 96
    Notes: Sales, means the sales volume of Hair Loss and growth Treatments and Products Revenue, means the sales value of Hair Loss and growth Treatments and Products This report studies sales (consumption) of Hair Loss and growth Treatments and Products in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Cipla - Viviscal - Dr. Reddy's Laboratories Ltd. - Regaine ......
  • Global Anesthesia Gas Monitoring Device Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 112
    Notes: Sales, means the sales volume of Anesthesia Gas Monitoring Device Revenue, means the sales value of Anesthesia Gas Monitoring Device This report studies sales (consumption) of Anesthesia Gas Monitoring Device in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Drgerwerk - GE Healthcare ......
  • United States PARP Inhibitors Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 103
    Notes: Sales, means the sales volume of PARP Inhibitors Revenue, means the sales value of PARP Inhibitors This report studies sales (consumption) of PARP Inhibitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - AstraZeneca PLC - AbbVie Inc - Clovis Oncology, Inc - Medivation, Inc - Tesaro, Inc. - ... Split by product types, with sale......
  • United States, EU, Japan, China, India and Southeast Asia 3D Bioprinting Technology Market Size, Status and Forecast 2021
    Published: 01-Dec-2016        Price: US 3300 Onwards        Pages: 106
    Notes: Production, means the output of 3D Bioprinting Technology Revenue, means the sales value of 3D Bioprinting Technology This report studies the global 3D Bioprinting Technology market, analyzes and researches the 3D Bioprinting Technology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - 3D Biotek, LLC - 3Dynamic Systems Ltd - Accellta......
  • Europe Anti Obesity Drugs Market Report 2016
    Published: 01-Dec-2016        Price: US 3900 Onwards        Pages: 119
    Notes: Sales, means the sales volume of Anti Obesity Drugs Revenue, means the sales value of Anti Obesity Drugs This report studies sales (consumption) of Anti Obesity Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Merck - Roche - GlaxoSmithKline ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs